Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: D. K. G. who wrote (7129)	3/15/2005 6:23:42 PM
From: Sergio H	Read Replies (1) \| Respond to of 23958

Thanks DKG. I'm also looking forward to CRNS' earnings and keep an eye on it to add trading shares when possible. It trades thinly, so its not a good daytrader, but opportunities do come up. INKF Looks good but just not yet. I put it on my watchlist for now.

To: D. K. G. who wrote (7129)	6/23/2005 10:21:07 PM
From: D. K. G.	Read Replies (1) \| Respond to of 23958

4:11PM Inkine Pharm to be acquired by Salix Pharma for $3.55/share (INKP) 2.17 +0.07:Salix Pharma (SLXP) and InKine Pharma (INKP) announce that the two companies have entered into a definitive merger agreement under which InKine stockholders will receive Salix common stock valued at $3.55 per share of InKine common stock, or approx $190 mln in equity value. On a GAAP basis, the transaction is expected to be EPS neutral to Salix in 2006 and significantly accretive thereafter. ============================================== I made some $$$ but seems too cheap. Shareholders are getting ripped off!